Acid Fast Suspectibility - 10 drugs (BACTEC)

A positive acid-fast bacillus (AFB) culture means viable acid-fast organisms—commonly Mycobacterium tuberculosis complex or non-tuberculous mycobacteria—have grown from the specimen. It suggests active infection when clinical and radiologic findings support disease. Further laboratory workup (species identification and drug-susceptibility testing) and clinical correlation are required to guide treatment and infection-control measures, since colonization or contamination can sometimes occur.

DST refers to drug susceptibility testing, not a medication. It's a laboratory test that identifies which antibiotics—or anti‑tuberculosis drugs—will effectively kill a bacterial strain. DST guides selection of first‑ or second‑line therapy, detects multidrug‑resistant and extensively drug‑resistant TB, and uses phenotypic culture methods plus molecular assays to speed diagnosis and optimize treatment.

The acid-fast test (Ziehl–Neelsen or fluorescent staining) detects Mycobacterium tuberculosis in respiratory samples by exploiting its mycolic-acid–rich cell wall: acid-fast bacilli retain stain after acid-alcohol decolorization. Microscopy offers rapid evidence of TB and contagiousness but is less sensitive than culture or molecular tests. Positive smears prompt immediate treatment and infection control; culture or PCR confirm diagnosis and drug susceptibility.

I can't provide step‑by‑step culturing instructions; here's a brief overview. Growing acid‑fast bacteria (e.g., Mycobacterium) requires specialized laboratory facilities, selective media, prolonged incubation and strict biosafety controls. Isolation and identification are done in accredited clinical or public‑health labs using culture plus microscopy and molecular tests. Because these organisms can cause serious disease, culturing should only be performed by authorized laboratories; consult healthcare services.

TB sensitivity is assessed by drug susceptibility testing (DST). Rapid molecular tests such as Xpert MTB/RIF detect Mycobacterium tuberculosis and rifampicin resistance; line probe assays identify resistance to first- and second-line drugs. Phenotypic culture-based DST (MGIT or agar proportion) confirms susceptibility across anti-TB medications. Testing uses sputum or cultured isolates to guide appropriate therapy.

Typically two sputum samples are collected for diagnosing pulmonary TB: a spot specimen and an early‑morning specimen. Many programs still collect three samples in certain situations to increase sensitivity, especially if initial smears are negative or for high‑risk patients. Samples should be properly collected, labeled and sent for microscopy, culture and molecular testing (e.g., NAAT) per local protocols.